​

Funding Round

Series D - Regentis Biomaterials

Series D - Regentis Biomaterials

Investment Firm

Overview

Regentis Biomaterials develops and commercializes proprietary hydrogels for tissue regeneration.

Announced Date

Feb 07, 2016

Funding Type

Series D

Highlights

Location

Asia

Social

Investor Lead

Haisco

Haisco

No designation

Participant Investors

5

Investor Name
Participant InvestorHaisco
Participant InvestorT3
Participant InvestorGenerali Investments Europe
Participant InvestorMedica Venture Partners
Participant InvestorSCP Vitalife Partners

Round Details and Background

Regentis Biomaterials raised $15000000 on 2016-02-07 in Series D

Regentis Biomaterials develops and commercializes proprietary hydrogels for tissue regeneration.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 01, 2004
Seed Round - Regentis Biomaterials
-undefined
Aug 21, 2007
Series B - Regentis Biomaterials
2-7.5M
Feb 07, 2016
Series D - Regentis Biomaterials
5-15.0M
May 14, 2012
Series C - Regentis Biomaterials
3-10.0M

Recent Activity

There is no recent news or activity for this profile.